Campbell & CO Investment Adviser LLC Catalyst Pharmaceuticals, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.53 Billion
- Q2 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 43,541 shares of CPRX stock, worth $907,394. This represents 0.06% of its overall portfolio holdings.
Number of Shares
43,541
Previous 95,079
54.21%
Holding current value
$907,394
Previous $2.31 Million
59.05%
% of portfolio
0.06%
Previous 0.18%
Shares
11 transactions
Others Institutions Holding CPRX
# of Institutions
387Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$390 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$183 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$114 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$67.8 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$66.3 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.14B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...